KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Change in Accured Expenses (2016 - 2025)

Arbutus Biopharma's Change in Accured Expenses history spans 17 years, with the latest figure at -$177000.0 for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses fell 42.74% to -$177000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$557000.0, a 29.53% decrease, with the full-year FY2025 number at -$557000.0, down 29.53% from a year prior.
  • Change in Accured Expenses hit -$177000.0 in Q4 2025 for Arbutus Biopharma, down from $2.7 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for ABUS hit a ceiling of $5.8 million in Q4 2023 and a floor of -$7.6 million in Q2 2025.
  • Historically, Change in Accured Expenses has averaged $284800.0 across 5 years, with a median of -$73000.0 in 2023.
  • The widest YoY moves for Change in Accured Expenses: up 6412.5% in 2025, down 9644.87% in 2025.
  • Tracing ABUS's Change in Accured Expenses over 5 years: stood at $2.2 million in 2021, then skyrocketed by 74.56% to $3.8 million in 2022, then surged by 53.7% to $5.8 million in 2023, then plummeted by 102.15% to -$124000.0 in 2024, then crashed by 42.74% to -$177000.0 in 2025.
  • Business Quant data shows Change in Accured Expenses for ABUS at -$177000.0 in Q4 2025, $2.7 million in Q3 2025, and -$7.6 million in Q2 2025.